Symbols / NBY $1.95 +22.64% NovaBay Pharmaceuticals Inc

Healthcare • Biotechnology • United States • ASE
NBY Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Michael Kazley
Exch · Country ASE · United States
Market Cap 51.92M
Enterprise Value 45.09M
Income -33.22M
Sales —
FCF (ttm) -4.94M
Book/sh -0.92
Cash/sh 0.30
Employees 2
Insider 10d —
IPO Apr 26, 2000
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 0.05
Forward P/E -2.38
PEG —
P/S —
P/B —
P/C —
EV/EBITDA -5.95
EV/Sales —
Quick Ratio 6.97
Current Ratio 7.60
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -28.50
EPS next Y -0.82
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2025-08-12
Earnings (prior) 2025-08-12
ROA -76.11%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 3.50%
Profit Margin 0.00%
Shs Outstand 26.63M
Shs Float 2.62M
Insider Own 90.14%
Instit Own 5.34%
Short Float 9.79%
Short Ratio 0.69
Short Interest 333.12K
52W High 99.75
vs 52W High -98.05%
52W Low 1.11
vs 52W Low 75.68%
Beta 0.16
Impl. Vol. —
Rel Volume 1.35
Avg Volume 462.47K
Volume 626.37K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.59
Price $1.95
Change 22.64%
About

NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.95
Latest analyst target
3. DCF / Fair value
$-3.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.95
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-11-11 main Ascendiant Capital Buy → Buy $1
2023-08-11 main Ladenburg Thalmann Buy → Buy $4
News
RSS: Latest NBY news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-10-21 LAZAR DAVID ELLIOT Beneficial Owner of more than 10% of a Class of Security — 6,388,000 — —
2025-10-21 LAZAR DAVID ELLIOT Beneficial Owner of more than 10% of a Class of Security — 6,388,000 $99.08 $632,923,040
2025-10-21 R01 FUND L.P. Beneficial Owner of more than 10% of a Class of Security — 56,806,080 — —
2025-10-21 KAZLEY MICHAEL JOHN Chief Executive Officer — 56,806,080 — —
2025-10-21 FRAMEWORK VENTURES IV L.P. Beneficial Owner of more than 10% of a Class of Security — 56,806,080 — —
2025-04-08 POPLAR POINT CAPITAL PARTNERS L P Beneficial Owner of more than 10% of a Class of Security — 28,731 $0.46 $15,967
2025-04-01 POPLAR POINT CAPITAL PARTNERS L P Beneficial Owner of more than 10% of a Class of Security — 123,365 $0.58 $74,519
2025-03-25 POPLAR POINT CAPITAL PARTNERS L P Beneficial Owner of more than 10% of a Class of Security — 49,927 $0.60 $30,718
2025-03-18 POPLAR POINT CAPITAL PARTNERS L P Beneficial Owner of more than 10% of a Class of Security — 64,175 $0.58 $39,503
2025-03-07 POPLAR POINT CAPITAL PARTNERS L P Beneficial Owner of more than 10% of a Class of Security — 48,930 $0.55 $29,858
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
-100.00%
10.46
-27.42%
14.40
Operating Revenue
0.00
0.00
-100.00%
10.46
-27.26%
14.37
Cost Of Revenue
—
3.30
-24.50%
4.37
-34.00%
6.62
Reconciled Cost Of Revenue
—
3.30
-24.50%
4.37
-34.00%
6.62
Gross Profit
—
6.48
+6.53%
6.08
-21.81%
7.78
Operating Expense
7.58
+2.79%
7.38
-27.56%
10.19
-34.12%
15.46
Research And Development
—
0.04
+23.53%
0.03
-80.46%
0.17
Selling General And Administration
7.58
+2.79%
7.38
-27.31%
10.15
-33.59%
15.29
Selling And Marketing Expense
—
4.03
-14.26%
4.71
-39.66%
7.80
General And Administrative Expense
7.58
+2.79%
7.38
+35.47%
5.45
-27.27%
7.49
Other Gand A
7.58
+2.79%
7.38
+35.47%
5.45
-27.27%
7.49
Total Expenses
7.58
+2.79%
7.38
-49.31%
14.56
-34.08%
22.08
Operating Income
-7.58
-2.79%
-7.38
-79.89%
-4.10
+46.59%
-7.68
Total Operating Income As Reported
-8.44
-14.37%
-7.38
-79.89%
-4.10
+71.55%
-14.42
EBITDA
-32.80
-337.11%
-7.50
-83.27%
-4.09
+43.10%
-7.20
Normalized EBITDA
-7.46
+2.02%
-7.62
-72.88%
-4.41
+3.04%
-4.54
Reconciled Depreciation
0.14
-58.94%
0.34
-4.21%
0.36
-26.29%
0.48
EBIT
-32.95
-319.90%
-7.85
-76.27%
-4.45
+42.04%
-7.68
Total Unusual Items
-25.34
-22328.07%
0.11
-63.46%
0.31
+111.76%
-2.65
Total Unusual Items Excluding Goodwill
-25.34
-22328.07%
0.11
-63.46%
0.31
+111.76%
-2.65
Special Income Charges
-0.85
0.00
0.00
+100.00%
-6.18
Other Special Charges
—
0.01
—
—
Impairment Of Capital Assets
0.85
0.00
-100.00%
2.59
-61.51%
6.74
Restructuring And Mergern Acquisition
—
—
0.00
+100.00%
-0.56
Net Income
-22.14
-206.53%
-7.22
+25.07%
-9.64
+9.13%
-10.61
Pretax Income
-33.22
-279.68%
-8.75
-42.39%
-6.14
+42.07%
-10.61
Net Non Operating Interest Income Expense
-0.28
+69.36%
-0.90
+46.64%
-1.69
—
Interest Expense Non Operating
0.28
-69.36%
0.90
-46.64%
1.69
—
Net Interest Income
-0.28
+69.36%
-0.90
+46.64%
-1.69
—
Interest Expense
0.28
-69.36%
0.90
-46.64%
1.69
—
Other Income Expense
-25.36
-5330.41%
-0.47
-33.81%
-0.35
+88.08%
-2.93
Other Non Operating Income Expenses
-0.02
+96.56%
-0.58
+12.10%
-0.66
-139.49%
-0.28
Gain On Sale Of Security
-24.49
-21578.95%
0.11
-63.46%
0.31
-91.15%
3.52
Gain On Sale Of Business
—
-0.86
0.00
—
Tax Provision
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-22.14
-206.53%
-7.22
+25.07%
-9.64
+9.13%
-10.61
Net Income From Continuing Operation Net Minority Interest
-33.22
-279.68%
-8.75
-42.39%
-6.14
+42.07%
-10.61
Net Income From Continuing And Discontinued Operation
-22.14
-206.53%
-7.22
+25.07%
-9.64
+9.13%
-10.61
Net Income Continuous Operations
-33.22
-279.68%
-8.75
-42.39%
-6.14
+42.07%
-10.61
Net Income Discontinuous Operations
11.08
+625.67%
1.53
+143.69%
-3.50
—
Normalized Income
-7.88
+11.08%
-8.86
-37.28%
-6.46
+18.84%
-7.96
Net Income Common Stockholders
-22.14
-157.21%
-8.61
+48.45%
-16.70
-2.66%
-16.27
Otherunder Preferred Stock Dividend
0.00
-100.00%
1.39
-80.37%
7.06
+24.75%
5.66
Diluted EPS
-19.00
-49.84%
-12.68
+98.18%
-695.70
+60.64%
-1,767.50
Basic EPS
-19.00
-49.84%
-12.68
+98.18%
-695.70
+60.64%
-1,767.50
Basic Average Shares
1.16
+71.43%
0.68
+2729.17%
0.02
+160.87%
0.01
Diluted Average Shares
1.16
+71.43%
0.68
+2729.17%
0.02
+160.87%
0.01
Diluted NI Availto Com Stockholders
-22.14
-157.21%
-8.61
+48.45%
-16.70
-2.66%
-16.27
Preferred Stock Dividends
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
9.04
+163.95%
3.42
-62.11%
9.03
-44.91%
16.40
Current Assets
8.68
+348.32%
1.94
-72.95%
7.15
-36.87%
11.33
Cash Cash Equivalents And Short Term Investments
7.96
+1750.70%
0.43
-85.29%
2.92
-45.47%
5.36
Cash And Cash Equivalents
7.96
+1750.70%
0.43
-85.29%
2.92
-45.47%
5.36
Receivables
—
0.47
-39.22%
0.77
-62.05%
2.02
Accounts Receivable
—
0.39
-42.79%
0.68
-65.53%
1.97
Gross Accounts Receivable
—
0.39
-42.61%
0.68
-65.71%
1.99
Allowance For Doubtful Accounts Receivable
—
-0.00
+0.00%
-0.00
+84.21%
-0.02
Other Receivables
—
0.08
-10.59%
0.09
+97.67%
0.04
Inventory
—
0.77
+52.69%
0.50
-85.42%
3.44
Raw Materials
—
0.13
-86.53%
0.94
-25.92%
1.27
Finished Goods
—
0.79
-63.47%
2.17
-18.59%
2.66
Prepaid Assets
0.30
+522.92%
0.05
-46.67%
0.09
-74.86%
0.36
Current Deferred Assets
0.24
0.00
—
—
Assets Held For Sale Current
0.00
-100.00%
1.23
-55.85%
2.79
—
Other Current Assets
0.18
-20.98%
0.22
+176.54%
0.08
-49.06%
0.16
Total Non Current Assets
0.36
-75.81%
1.49
-20.85%
1.88
-62.90%
5.07
Net PPE
0.00
-100.00%
0.95
-30.95%
1.38
-29.08%
1.95
Gross PPE
0.00
-100.00%
0.95
-53.55%
2.06
-20.06%
2.57
Accumulated Depreciation
—
-0.69
-2.38%
-0.67
-8.20%
-0.62
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.00
-100.00%
0.95
-26.31%
1.30
-29.22%
1.83
Machinery Furniture Equipment
—
0.59
-2.96%
0.61
+3.23%
0.59
Other Properties
—
—
—
1.83
Leases
—
0.15
+0.00%
0.15
+0.00%
0.15
Goodwill And Other Intangible Assets
—
—
0.00
-100.00%
2.63
Goodwill
—
—
0.00
-100.00%
0.35
Other Intangible Assets
—
—
—
2.28
Other Non Current Assets
0.36
-32.46%
0.53
+7.24%
0.50
+1.64%
0.49
Total Liabilities Net Minority Interest
32.21
+806.84%
3.55
-37.90%
5.72
-2.14%
5.84
Current Liabilities
1.14
-59.83%
2.84
-33.54%
4.28
+0.49%
4.26
Payables And Accrued Expenses
0.65
-5.36%
0.69
-38.88%
1.13
-43.47%
2.00
Payables
0.50
+362.39%
0.11
-87.97%
0.91
-16.11%
1.08
Accounts Payable
0.26
+135.78%
0.11
-87.97%
0.91
-16.11%
1.08
Current Accrued Expenses
0.15
-74.35%
0.58
+160.54%
0.22
-75.68%
0.92
Total Tax Payable
0.25
0.00
—
—
Current Debt And Capital Lease Obligation
0.49
-49.22%
0.96
-36.01%
1.50
+232.23%
0.45
Current Debt
0.07
-88.14%
0.56
-50.31%
1.14
—
Other Current Borrowings
0.07
-88.14%
0.56
-50.31%
1.14
—
Current Capital Lease Obligation
0.42
+6.03%
0.40
+8.15%
0.37
-18.76%
0.45
Current Deferred Liabilities
—
0.49
-48.41%
0.95
-47.65%
1.81
Current Deferred Revenue
—
0.49
-48.41%
0.95
-47.65%
1.81
Other Current Liabilities
—
1.19
+70.49%
0.70
—
Total Non Current Liabilities Net Minority Interest
31.07
+4282.09%
0.71
-50.83%
1.44
-9.19%
1.59
Long Term Debt And Capital Lease Obligation
0.29
-59.52%
0.71
-36.01%
1.11
-30.23%
1.59
Long Term Capital Lease Obligation
0.29
-59.52%
0.71
-36.01%
1.11
-30.23%
1.59
Other Non Current Liabilities
—
—
0.33
—
Preferred Securities Outside Stock Equity
0.35
0.00
—
—
Stockholders Equity
-23.18
-17865.89%
-0.13
-103.89%
3.31
-68.60%
10.55
Common Stock Equity
-23.18
-17071.85%
-0.14
-109.90%
1.36
-82.01%
7.58
Capital Stock
0.26
+1512.50%
0.02
-99.18%
1.95
-34.75%
2.99
Common Stock
0.25
+2420.00%
0.01
+233.33%
0.00
-85.00%
0.02
Preferred Stock
0.01
+0.00%
0.01
-99.69%
1.95
-34.41%
2.97
Share Issued
25.22
+2480.60%
0.98
+1422.69%
0.06
+451.87%
0.01
Ordinary Shares Number
25.22
+2480.60%
0.98
+1422.69%
0.06
+451.87%
0.01
Additional Paid In Capital
186.98
+2.00%
183.31
+4.03%
176.21
+6.33%
165.71
Retained Earnings
-210.41
-14.69%
-183.46
-4.92%
-174.85
-10.56%
-158.15
Total Equity Gross Minority Interest
-23.18
-17865.89%
-0.13
-103.89%
3.31
-68.60%
10.55
Total Capitalization
-23.18
-17865.89%
-0.13
-103.89%
3.31
-68.60%
10.55
Working Capital
7.53
+929.63%
-0.91
-131.57%
2.88
-59.35%
7.08
Invested Capital
-23.11
-5475.58%
0.43
-82.81%
2.50
-67.01%
7.58
Total Debt
0.78
-53.59%
1.67
-36.01%
2.61
+28.03%
2.04
Net Debt
—
0.14
—
—
Capital Lease Obligations
0.71
-35.95%
1.11
-25.00%
1.48
-27.68%
2.04
Net Tangible Assets
-23.18
-17865.89%
-0.13
-103.89%
3.31
-58.19%
7.93
Tangible Book Value
-23.18
-17071.85%
-0.14
-109.90%
1.36
-72.46%
4.95
Derivative Product Liabilities
30.43
0.00
-100.00%
0.33
0.00
Interest Payable
0.06
+56.76%
0.04
—
—
Inventories Adjustments Allowances
—
-0.11
+59.85%
-0.26
+47.09%
-0.50
Line Of Credit
—
—
—
0.00
Other Inventories
—
-0.05
+97.95%
-2.35
—
Preferred Stock Equity
0.01
+0.00%
0.01
-99.69%
1.95
-34.41%
2.97
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.43
-12.44%
-7.50
-75.94%
-4.26
+35.96%
-6.65
Cash Flow From Continuing Operating Activities
-8.43
-12.44%
-7.50
-75.94%
-4.26
+35.96%
-6.65
Net Income From Continuing Operations
-33.22
-279.68%
-8.75
-52.41%
-5.74
+45.88%
-10.61
Depreciation Amortization Depletion
0.14
-58.94%
0.34
-4.21%
0.36
-26.29%
0.48
Depreciation
0.14
-58.94%
0.34
-4.21%
0.36
+196.67%
0.12
Amortization Cash Flow
—
—
0.15
-58.13%
0.36
Depreciation And Amortization
0.14
-58.94%
0.34
-4.21%
0.36
-26.29%
0.48
Amortization Of Intangibles
—
—
0.15
-58.13%
0.36
Other Non Cash Items
0.25
-80.02%
1.24
-3.50%
1.29
+329.23%
-0.56
Stock Based Compensation
0.03
-80.41%
0.15
-49.14%
0.29
+32.27%
0.22
Asset Impairment Charge
0.85
0.00
-100.00%
2.60
-61.86%
6.80
Operating Gains Losses
24.49
+175000.00%
-0.01
+30.00%
-0.02
+99.43%
-3.52
Gain Loss On Investment Securities
24.49
+90788.89%
-0.03
-35.00%
-0.02
+99.43%
-3.52
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
-0.96
-108.42%
-0.46
-6.93%
-0.43
-181.24%
0.53
Change In Receivables
—
0.29
-65.60%
0.85
+377.38%
-0.30
Changes In Account Receivables
—
0.29
-65.60%
0.85
+377.38%
-0.30
Change In Inventory
—
-0.27
-267.90%
0.16
+174.65%
-0.22
Change In Prepaid Assets
-0.45
-584.62%
-0.07
-690.91%
0.01
-94.95%
0.22
Change In Payables And Accrued Expense
-0.04
+35.09%
-0.06
+94.94%
-1.13
-268.97%
0.67
Change In Payable
-0.04
+35.09%
-0.06
+94.94%
-1.13
-268.97%
0.67
Change In Account Payable
-0.04
+35.09%
-0.06
+94.94%
-1.13
-268.97%
0.67
Change In Other Current Assets
-0.09
-403.57%
0.03
+566.67%
-0.01
+99.58%
-1.43
Change In Other Current Liabilities
-0.40
-7.86%
-0.37
-15.67%
-0.32
-120.00%
1.59
Investing Cash Flow
—
1.06
+5700.00%
-0.02
+83.04%
-0.11
Cash Flow From Continuing Investing Activities
—
1.06
+5700.00%
-0.02
+83.04%
-0.11
Net PPE Purchase And Sale
—
-0.01
+68.42%
-0.02
+83.04%
-0.11
Purchase Of PPE
—
-0.01
+68.42%
-0.02
+83.04%
-0.11
Capital Expenditure
—
-0.01
+68.42%
-0.02
+83.04%
-0.11
Net Business Purchase And Sale
—
1.07
0.00
0.00
Purchase Of Business
—
—
—
0.00
Gain Loss On Sale Of Business
—
0.86
0.00
—
Financing Cash Flow
4.62
+207.87%
1.50
-21.52%
1.91
-58.77%
4.63
Cash Flow From Continuing Financing Activities
4.62
+207.87%
1.50
-21.52%
1.91
-58.77%
4.63
Net Issuance Payments Of Debt
-2.50
-67.74%
-1.49
-197.71%
1.53
+1553.33%
-0.10
Issuance Of Debt
0.00
-100.00%
0.50
-83.33%
3.00
0.00
Repayment Of Debt
-2.50
-25.62%
-1.99
-35.07%
-1.47
-1303.81%
-0.10
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
-2.50
0.00
—
—
Net Long Term Debt Issuance
-2.50
0.00
—
—
Short Term Debt Issuance
0.00
-100.00%
0.50
-83.33%
3.00
0.00
Short Term Debt Payments
0.00
+100.00%
-1.99
-35.07%
-1.47
-1303.81%
-0.10
Net Short Term Debt Issuance
0.00
+100.00%
-1.49
-197.71%
1.53
+1553.33%
-0.10
Net Common Stock Issuance
2.05
-28.31%
2.86
0.00
0.00
Common Stock Dividend Paid
-4.82
0.00
—
—
Cash Dividends Paid
-4.82
0.00
—
—
Repurchase Of Capital Stock
-0.17
0.00
—
—
Proceeds From Stock Option Exercised
6.27
+2439.68%
0.25
-56.28%
0.56
-66.82%
1.70
Net Other Financing Charges
—
-0.12
+36.46%
-0.18
—
Changes In Cash
7.32
+371.14%
-2.70
+1.60%
-2.74
-28.60%
-2.13
Beginning Cash Position
0.91
-74.85%
3.61
-38.32%
5.85
-26.73%
7.98
End Cash Position
8.22
+806.84%
0.91
-73.32%
3.40
-41.84%
5.85
Free Cash Flow
-8.43
-12.44%
-7.50
-75.16%
-4.28
+36.74%
-6.77
Interest Paid Supplemental Data
—
0.15
-22.22%
0.19
+1011.76%
0.02
Income Tax Paid Supplemental Data
—
—
0.36
+1395.83%
0.02
Common Stock Issuance
2.05
-28.31%
2.86
0.00
0.00
Issuance Of Capital Stock
5.83
+104.16%
2.86
0.00
-100.00%
3.04
Net Preferred Stock Issuance
3.61
0.00
0.00
-100.00%
3.04
Other Cash Adjustment Outside Changein Cash
—
0.13
-57.58%
0.30
—
Preferred Stock Issuance
3.79
0.00
0.00
-100.00%
3.04
Preferred Stock Payments
-0.17
0.00
—
—
Sale Of Business
—
1.07
0.00
—
Cash Flow From Discontinued Operation
—
-0.21
+44.77%
-0.37
—
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category